Prestige Consumer Healthcare (PBH) Stock Statistics & Valuation Metrics

Prestige Consumer Healthcare has a market cap or net worth of $2.34B. The enterprise value is $3.17B.

Prestige Consumer Healthcare has 47,372,166 shares outstanding. The number of shares has decreased by -2.65% in one year.

Prestige Consumer Healthcare’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.65%.

The current PE Ratio of Prestige Consumer Healthcare is 12.5. Prestige Consumer Healthcare’s PEG ratio is -1.67.

In the last 12 months, Prestige Consumer Healthcare had revenue of 1.09B and earned 190.30M in profits. Earnings per share was 3.93.

In the last 12 months, operating cash flow was 265.41M and capital expenditures -11.18M, giving a free cash flow of 254.23M billion.

Prestige Consumer Healthcare pays an annual dividend of $0.475, resulting in a dividend yield of ―

Prestige Consumer Healthcare upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).

Prestige Consumer Healthcare as a current ratio of 3.57, with Debt / Equity ratio of 55.39%

In the past 12 months, Prestige Consumer Healthcare has paid 67.19M in taxes.

Prestige Consumer Healthcare EV to EBITDA ratio is 11.64, with an EV/FCF ratio of 15.16.

Prestige Consumer Healthcare has $63.87M in cash and marketable securities with $1.05B in debt, giving a net cash position of -$981.56M billion.

Gross margin is 53.96%, with operating margin of 28.42%, and net profit margin of 17.48%.

The average price target for Prestige Consumer Healthcare is $72.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy